Skip to main content

Zygel FDA Approval Status

FDA Approved: No
Brand name: Zygel
Generic name: cannabidiol
Dosage form: Gel
Company: Zynerba Pharmaceuticals, Inc.
Treatment for: Behavioral Symptoms associated with Fragile X Syndrome

Zygel (cannabidiol gel) is a transdermal gel formulation of cannabidiol (CBD) in development for the treatment of behavioral symptoms associated with Fragile X Syndrome (FXS).

Development Timeline for Zygel

DateArticle
May  6, 2019Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)
Aug  7, 2017Zynerba Pharmaceuticals Announces Top-Line Results from Phase 2 STAR 1 Trial of ZYN002 in Adult Epilepsy Patients with Focal Seizures

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.